The study performed by Pellagatti et al. that investigated 41 MDS cases before and after the progression of MDS showed that ASXL1, encoding an essential epigenetic regulator, was the most frequently mutated gene, with a rate of mutation around 44–46% being strongly associated with leukemic transformation [57]. The gene discussed is ASXL1; the disease is myelodysplastic syndrome.